Conmed Corp
CNMD40.770USD
+0.600+1.49%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
1.26BMarket Cap
19.71P/E TTM
More Details of Conmed Corp Company
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Conmed Corp Info
Ticker SymbolCNMD
Company nameConmed Corp
IPO dateJul 23, 1987
CEOBeyer (Patrick J)
Number of employees3900
Security typeOrdinary Share
Fiscal year-endJul 23
Address11311 Concept Boulevard
CityLARGO
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code33773
Phone17272142974
Websitehttps://www.conmed.com/
Ticker SymbolCNMD
IPO dateJul 23, 1987
CEOBeyer (Patrick J)
Company Executives of Conmed Corp
Name
Name/Position
Position
Shareholding
Change
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.13K
+18.20%
Mr. Kim Kelderman
Mr. Kim Kelderman
Independent Director
Independent Director
--
--
Mr. Richard Glaze
Mr. Richard Glaze
Chief Information Officer
Chief Information Officer
--
-100.00%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
By RegionUSD
Name
Revenue
Proportion
United States
190.61M
55.68%
Europe & Middle East & Africa
63.92M
18.67%
Asia Pacific
42.07M
12.29%
Americas (excluding the United States)
31.88M
9.31%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
Shareholding Stats
Updated: Sun, Nov 30
Updated: Sun, Nov 30
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.90%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.04%
Fuller & Thaler Asset Management Inc.
5.60%
Westwood Management Corp. (Texas)
4.29%
Other
55.53%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.90%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.04%
Fuller & Thaler Asset Management Inc.
5.60%
Westwood Management Corp. (Texas)
4.29%
Other
55.53%
Shareholder Types
Shareholders
Proportion
Investment Advisor
55.01%
Investment Advisor/Hedge Fund
46.65%
Hedge Fund
7.01%
Research Firm
2.89%
Pension Fund
1.93%
Bank and Trust
0.68%
Individual Investor
0.59%
Sovereign Wealth Fund
0.06%
Insurance Company
0.04%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
638
36.30M
136.51%
+226.00
2025Q3
655
36.31M
137.32%
-1.03M
2025Q2
649
37.27M
138.33%
-832.15K
2025Q1
642
38.16M
137.89%
-4.49M
2024Q4
628
38.56M
133.23%
+1.56M
2024Q3
620
37.00M
134.64%
-1.79M
2024Q2
640
38.79M
129.72%
+1.14M
2024Q1
637
37.49M
133.32%
-3.56M
2023Q4
623
39.15M
131.18%
+747.69K
2023Q3
604
38.42M
132.14%
+127.38K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
4.43M
14.3%
-133.34K
-2.92%
Jun 30, 2025
The Vanguard Group, Inc.
3.54M
11.44%
+42.41K
+1.21%
Jun 30, 2025
EARNEST Partners, LLC
2.83M
9.14%
+30.22K
+1.08%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.74M
5.62%
+566.60K
+48.26%
Jun 30, 2025
Westwood Management Corp. (Texas)
1.24M
4%
-484.00
-0.04%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.08M
3.5%
+184.21K
+20.50%
Jun 30, 2025
State Street Investment Management (US)
1.29M
4.18%
-8.83K
-0.68%
Jun 30, 2025
Managed Account Advisors LLC
1.38M
4.47%
+103.77K
+8.11%
Jun 30, 2025
Silvercrest Asset Management Group LLC
851.95K
2.75%
-183.66K
-17.73%
Jun 30, 2025
Capital Research Global Investors
1.68M
5.41%
+2.76K
+0.16%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
1.48%
ROBO Global Healthcare Technology & Innovation ETF
1.05%
Invesco S&P SmallCap Health Care ETF
0.83%
Harbor Human Capital Factor US Small Cap ETF
0.56%
First Trust Small Cap Value AlphaDEX Fund
0.49%
VictoryShares Small Cap Free Cash Flow ETF
0.36%
WisdomTree US SmallCap Quality Dividend Growth
0.24%
First Trust Small Cap Core Alphadex Fund
0.24%
Lattice Hartford Multifactor Small Cap ETF
0.23%
Franklin US Small Cap Multifactor Index ETF
0.2%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion1.48%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.05%
Invesco S&P SmallCap Health Care ETF
Proportion0.83%
Harbor Human Capital Factor US Small Cap ETF
Proportion0.56%
First Trust Small Cap Value AlphaDEX Fund
Proportion0.49%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.36%
WisdomTree US SmallCap Quality Dividend Growth
Proportion0.24%
First Trust Small Cap Core Alphadex Fund
Proportion0.24%
Lattice Hartford Multifactor Small Cap ETF
Proportion0.23%
Franklin US Small Cap Multifactor Index ETF
Proportion0.2%
Dividend
A total of
119.19M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Aug 08, 2025
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 03, 2025 going ex on Sep 15, 2025
Sep 15, 2025
Oct 03, 2025
Sep 15, 2025
May 21, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 03, 2025 going ex on Jun 13, 2025
Jun 13, 2025
Jul 03, 2025
Jun 13, 2025
Feb 25, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 04, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 04, 2025
Mar 14, 2025
Dec 10, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 03, 2025 going ex on Dec 20, 2024
Dec 20, 2024
Jan 03, 2025
Dec 20, 2024
Aug 09, 2024
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 04, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 04, 2024
Sep 16, 2024
May 22, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 26, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Dec 05, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2024 going ex on Dec 15, 2023
Dec 18, 2023
Jan 05, 2024
Dec 15, 2023
Aug 10, 2023
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 05, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 05, 2023
Sep 14, 2023
May 24, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 05, 2023
Jun 14, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Conmed Corp?
The top five shareholders of Conmed Corp are:
BlackRock Institutional Trust Company, N.A. holds 4.43M shares, accounting for 14.30% of the total shares.
The Vanguard Group, Inc. holds 3.54M shares, accounting for 11.44% of the total shares.
EARNEST Partners, LLC holds 2.83M shares, accounting for 9.14% of the total shares.
Fuller & Thaler Asset Management Inc. holds 1.74M shares, accounting for 5.62% of the total shares.
Westwood Management Corp. (Texas) holds 1.24M shares, accounting for 4.00% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 4.43M shares, accounting for 14.30% of the total shares.
The Vanguard Group, Inc. holds 3.54M shares, accounting for 11.44% of the total shares.
EARNEST Partners, LLC holds 2.83M shares, accounting for 9.14% of the total shares.
Fuller & Thaler Asset Management Inc. holds 1.74M shares, accounting for 5.62% of the total shares.
Westwood Management Corp. (Texas) holds 1.24M shares, accounting for 4.00% of the total shares.
What are the top three shareholder types of Conmed Corp?
The top three shareholder types of Conmed Corp are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
EARNEST Partners, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
EARNEST Partners, LLC
How many institutions hold shares of Conmed Corp (CNMD)?
As of 2025Q4, 638 institutions hold shares of Conmed Corp, with a combined market value of approximately 36.30M, accounting for 136.51% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.81%.
What is the biggest source of revenue for Conmed Corp?
In FY2025Q2, the General Surgery business generated the highest revenue for Conmed Corp, amounting to 201.61M and accounting for 58.89% of total revenue.
